DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/3x3kdb/global_human_vacci) has announced the addition of the "Global Human Vaccines Market 2011-2015" report to their offering.
TechNavio's analysts forecast the Global Human Vaccines market to reach US$57.6 billion by 2015. One of the key factors contributing to this market growth is the increase in demand for vaccination against communicable diseases. The Global Human Vaccines market has also been witnessing the increase in awareness programs worldwide. However, emergence of vaccine-resistant viruses could pose a challenge to the growth of this market.
TechNavio's report, the Global Human Vaccines Market 2011-2015, has been prepared based on an in-depth analysis of the market with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Human Vaccines market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key Questions Answered:
- What will the market size be in 2015 and at what rate will it grow?
- What key trends is this market subject to?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the opportunities and threats faced by each of these key vendors?
- What are the strengths and weaknesses of each of these key vendors?
Topics Covered:
1. Executive Summary
2. Introduction
3. Market Coverage
- Market Overview
- Key Products
4. Market Landscape
- Market Size
- Market Segmentation by Vaccine Application
- Market Segmentation by Consumers
- Market Size of Global Pediatric Vaccines Market
- Five Forces Analysis
5. Geographical Segmentation
6. Key Leading Countries
- USA
- Germany
- France
- UK
7. Rate of Incidence and Prevalence
8. Vendor Landscape
9. Buying Criteria
10. Market Growth Drivers
11. Drivers and their Impact
Drivers and their Impact: End-users
Drivers and their Impact: Geography
12. Market Challenges
13. Impact of Drivers and Challenges
14. Market Trends
15. Key Vendor Analysis
Companies Mentioned
- ALK Abello A/S
- AstraZeneca plc
- Bavarian Nordic A/S
- Baxter International Inc.
- CSL Ltd.
- GlaxoSmithKline plc
- MedImmune Inc.
- Merck and Co. Inc.
- Novartis AG
- Pfizer Inc.
- Sanofi S.A.
- Shanta Biotechnics Ltd.
- Sinovac Biotech Ltd.
- Vaxin Inc.
For more information, including full table of contents, please visit http://www.researchandmarkets.com/research/3x3kdb/global_human_vacci.